ACC NEWS why is Acc Limited price falling or rising
ACC NEWS reasons for why stock price of Acc Limited is falling or rising
ACC Acc is falling or rising technical reasons
Technical analysis forecast for Acc Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Acc ACC at this time. Stock is falling and might fall more.
It appears as if Acc ACC gave a large move recently.
Stock of Acc (ACC) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...
My analysis of Acc is bearish for shortterm, and stock might move down till 2396.5 or till 2264. Use a stoploss of 2506.96 and if the stock hits stoploss, then it can shoot up till 2617.38
ACC Acc is falling or rising NEWS fundamental reasons
Investing long-term? Start accumulating stocks which have been hammered 20-40%: Rahul Sharma Rahul Sharma suggests focusing on largecaps for alpha generation, while considering smallcaps and midcaps at discounted prices. Nifty's positive trend and sector leaders' performance support an optimistic outlook for FY25. Sharma says: "As we have seen i - NEWS as on 2024-03-28 indiatimes.com
Atoms 3.0: Accel's 6-mnth pre-seed accelerator program, unveils 8 startups The cohort receives up to 0,000 in funding, access to perks worth more than mn from venture capital firm Accel's network partners, personalised mentorship - NEWS as on 2024-03-28 business-standard.com
Dr Reddy's partners with Sanofi India to distribute vaccine brands in India Under the terms of this agreement, Dr Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands, including Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri and Adacel - NEWS as on 2024-03-27 business-standard.com
Dr Reddy's to promote, distribute Sanofi vaccine brands in India The announcement comes a day after Sanofi Healthcare India announced a separate partnership with Cipla to boost access to Sanofi's central nervous system medications across India. - NEWS as on 2024-03-27 indiatimes.com
Company Announcement - NEWS as on 2024-03-26
India's current account balance records deficit of US$ 10.5 billion in Q3:2023-24 India's current account balance recorded a deficit of US$ 10.5 billion (1.2 per cent of GDP) in Q3:2023-24, lower than US$ 11.4 billion (1.3 per cent of GDP) in Q2:2023-241 and US$ 16.8 billion (2.0 per cent of GDP) a year ago [i.e., Q3:2022-23]. The merch - NEWS as on 2024-03-26 business-standard.com
Silvercorp's Offer For OreCorp Lapses Due To Failure To Meet Minimum Acceptance Condition (RTTNews) - Silvercorp Metals Inc. (SVM, SVM.TO) said that, further to its off-market takeover bid for all of the ordinary shares in OreCorp Limited (ORR.AX), Silvercorp did not satisfy the 50.1% minimum acceptance condition prior to the close of the Offer - NEWS as on 2024-03-26 nasdaq.com
Starburst Accelerator, IIT Madras join hands for €100 million startup hub This partnership will enable export promotion and provide support for Indian ASD start-ups to explore international markets through the extensive network of Starburst - NEWS as on 2024-03-26 business-standard.com
Venture capital major Accel aims to invest in 25 Indian startups: Prashanth May launch India-focused fund in a few years - NEWS as on 2024-03-25 business-standard.com
Bharat Biotech begins clinical trials of TB vaccine on adults in India Bharat Biotech International Ltd has initiated clinical trials for the Tuberculosis vaccine Mtbvac on adults in India. Developed by the Spanish biopharmaceutical company Biofabri, Mtbvac is the first TB vaccine derived from a human source. The vaccine aims - NEWS as on 2024-03-24 indiatimes.com
Accenture's guidance cut likely to weigh on Indian IT sector: Analysts Companies likely heading to a slow start in FY25 as clients hold on to spending, they say - NEWS as on 2024-03-22 business-standard.com
Focus on IT stocks after Accenture lowers guidance, Nomura pessimistic on TCS, Wipro, LTIMindtree, LT Tech Following Accenture#39;s downward revision of revenue guidance, there are some fears raised on the pace of the revenue recovery for Indian IT. - NEWS as on 2024-03-22 moneycontrol.com
IT stocks tumbles after Accenture cuts FY24 guidance Shares of 10 IT companies witnessed substantial selling on Friday as IT bellwether, Accenture cuts FY24 earning forecast on clouded outlook. - NEWS as on 2024-03-22 business-standard.com
Accenture fans IT industry spending gloom with annual forecast cut Accenture now expects full-year revenue growth in the range of 1% to 3%, from its prior forecast of 2% to 5% - NEWS as on 2024-03-21 business-standard.com
Ultrahuman raises mn to accelerate growth, research in health space By collating a large set of biomarkers on an integrated platform across a range of products, Ultrahuman is able to create a grand unified view of the human body - NEWS as on 2024-03-21 business-standard.com
Reits seek changes in regulations to get easier access to capital They expect the Reit landscape, which is now limited to office space and retail, to expand to hotels, residential properties, data centres, and logistics - NEWS as on 2024-03-20 business-standard.com
Company Announcement ACC Limited has informed the Exchange regarding 'Clarification to media report under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended'. - NEWS as on 2024-03-19
Company Announcement ACC Limited has informed the Exchange regarding 'Intimation regarding change of registered office of the company.'. - NEWS as on 2024-03-11
Company Announcement ACC Limited has informed the Exchange about Schedule of meet - NEWS as on 2024-02-19
Company Announcement ACC Limited has informed the Exchange about Transcript - NEWS as on 2024-02-05
Company Announcement ACC Limited has informed the Exchange about Investor Presentation - NEWS as on 2024-01-31
Company Announcement ACC Limited has informed the Exchange about Loss of Share Certificates - NEWS as on 2024-01-30
Company Announcement ACC Limited has informed the Exchange about Schedule of meet of investors/analyst conference call on the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2023 on 31st January 2024 at - NEWS as on 2024-01-29
Company Announcement ACC Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2024-01-29
Company Announcement ACC Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 - NEWS as on 2024-01-04
More announcements and NEWS
ACC Acc Limited current price & indicator signals
Recent prices of ACC Acc Limited are as follows: Daily volume is divided by 10 day averaged volume
Date | Close | Range | Change % | Volume |
28 Thu Mar 2024 | 2491.70 | 2453.20 to 2505.00 | 1.53% | 0.96 times |
27 Wed Mar 2024 | 2454.10 | 2448.55 to 2500.00 | 0.17% | 1.06 times |
26 Tue Mar 2024 | 2450.00 | 2429.60 to 2477.20 | 0.28% | 0.55 times |
22 Fri Mar 2024 | 2443.25 | 2415.55 to 2458.00 | 0.18% | 0.97 times |
21 Thu Mar 2024 | 2438.85 | 2400.05 to 2450.90 | 1.72% | 0.42 times |
20 Wed Mar 2024 | 2397.70 | 2371.05 to 2431.45 | -0.24% | 0.65 times |
19 Tue Mar 2024 | 2403.40 | 2375.75 to 2449.85 | -1.56% | 1.01 times |
18 Mon Mar 2024 | 2441.55 | 2393.05 to 2480.10 | -2.45% | 1.81 times |
15 Fri Mar 2024 | 2502.95 | 2426.55 to 2523.95 | 0.84% | 0.99 times |
14 Thu Mar 2024 | 2482.10 | 2347.20 to 2489.30 | 3.89% | 1.04 times |
13 Wed Mar 2024 | 2389.10 | 2354.45 to 2575.65 | -6.73% | 1.51 times |
12 Tue Mar 2024 | 2561.60 | 2550.05 to 2659.35 | -3.04% | 0.85 times |
Videos related to: ACC NEWS why is Acc Limited price falling or rising
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance